NRC
MRK icon

New Republic Capital’s Merck MRK Stock Holding History

New Republic Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.06M Sell
8,749
-3,664
-30% -$423K 0.36% 52
2025
Q4 		$1.32M Buy
12,413
+6,192
+100% +$581K 0.35% 50
2025
Q3 		$527K Buy
6,221
+452
+8% +$37.2K 0.16% 87
2025
Q2 		$461K Buy
5,769
+430
+8% +$34.2K 0.16% 88
2025
Q1 		$483K Buy
5,339
+385
+8% +$35.9K 0.21% 81
2024
Q4 		$497K Buy
4,954
+389
+9% +$40.1K 0.32% 74
2024
Q3 		$522K Buy
4,565
+88
+2% +$10.5K 0.3% 77
2024
Q2 		$558K Buy
4,477
+93
+2% +$12K 0.28% 71
2024
Q1 		$582K Sell
4,384
-365
-8% -$45K 0.37% 64
2023
Q4 		$521K Buy
4,749
+1,137
+31% +$118K 0.37% 63
2023
Q3 		$374K Buy
3,612
+22
+0.6% +$2.37K 0.31% 74
2023
Q2 		$416K Buy
3,590
+302
+9% +$34.3K 0.29% 67
2023
Q1 		$352K Buy
3,288
+634
+24% +$68.5K 0.27% 75
2022
Q4 		$296K Buy
+2,654
New +$271K 0.23% 79

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

New Republic Capital's MRK Position: Q1 2026 in Review

New Republic Capital reduced its Merck (MRK) stake by 30% in Q1 2026, selling an estimated $423K and leaving 8,749 shares worth $1.06M. The position accounts for 0.36% of the portfolio, ranked #52.

New Republic Capital first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.32M in Q4 2025. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • New Republic Capital held 8,749 shares of Merck worth $1.06M as of Q1 2026.
  • New Republic Capital sold 3,664 Merck shares in Q1 2026, an estimated $423K.
  • Merck made up 0.36% of New Republic Capital's portfolio in Q1 2026, its #52 holding.
  • New Republic Capital first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • New Republic Capital's Merck position peaked at $1.32M in Q4 2025.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on New Republic Capital's 13F filing for Q1 2026, filed 1 May 2026.